72, 1263–1270; (c) S. Murahashi, N. Komiya, H. Terai and T.
Nakae, J. Am. Chem. Soc., 2003, 125, 15312–15313; (d) N. A.
Petasis, Multicompon. React., 2005, 199–223; (e) N. A. Petasis and
I. Akritopoulou, Tetrahedron Lett., 1993, 34, 583–586; (f) M. M.
Salter, J. Kobayashi, Y. Shimizu and S. Kobayashi, Org. Lett., 2006,
8, 3533–3536; (g) M. Suginome, L. Uehlin and M. Murakami, J. Am.
Chem. Soc., 2004, 126, 13196–13197; (h) S. Torchy and D. Barbry,
J. Chem. Res. Synop., 2001, 292–293.
3 (a) S. Caspe, J. Am. Chem. Soc., 1932, 54, 4457; (b) W. J. Hickinbot-
tom, J. Chem. Soc., 1930, 992–994; (c) Y. Ju and R. S. Varma, Green
Chem., 2004, 6, 219–221.
4 (a) Y. Nian, G. Xia, J. Li, Y. Zhu, and J. Shen, CN Pat., 1618791,
2005; (b) M. Zhuge, J. Deng, W. Ye, G. Zhang and N. Xing, CN Pat.,
1576273, 2005; (c) M. Capet, D. Danvy, N. Levoin, M. Morvan, I.
Berrebi-Bertrand, T. Calmels, P. Robert, J.-C. Schwartz, and J.-M.
Lecomte, US Pat., 2006089364, 2006.
Experimental
General procedure
To a mixture of arylpiperazine (1 eq), sodium iodide (0.3 eq),
magnesium sulfate (0.8 g) and cesium hydroxide (2 eq) was added
4-haloalkane (3–5 eq). The reaction mixture was stirred and
irradiated in a microwave oven (Ethos start) for an appropriate
time and temperature. After being cooled down, the mixture
was then taken up in 1 N NaOH and then extracted with AcOEt
(3 ¥ 30 mL). The organic layers were washed with water (2 ¥
30 mL), with brine (30 mL) and dried over anhydrous sodium
sulfate. Concentration of the solvent under reduced pressure and
drying in a oven under reduced pressure afforded the desired
alkylarylpiperazine.
5 (a) M. Larhed and A. Hallberg, Drug Discovery Today, 2001, 6, 406–
416; (b) V. Santagada, E. Perissutti, F. Fiorino, B. Vivenzio and G.
Caliendo, Tetrahedron Lett., 2001, 42, 2397–2400.
For the reactions carried out with 4-chorobutanol
2a, the corresponding desired product was isolated and
separated to secondary products by chromatographic column
with AcOEt/n-hexane as eluent. For example: 4-[4-(3,4-
6 (a) G. Bram, A. Loupy, M. Majdoub, E. Gutierrez and E. Ruiz-
Hitzky, Tetrahedron, 1990, 46, 5167–5176; (b) G. Bram, A. Loupy
and D. Villemin, Solid Supports Catal. Org. Synth., 1992, 302–
326; (c) E. Gutierrez, A. Loupy, G. Bram and E. Ruiz-Hitzky,
Tetrahedron Lett., 1989, 30, 945–948; (d) A. Loupy, Spectra Anal.,
1993, 22, 33–38; (e) A. Loupy, A. Petit, M. Ramdani, C. Yvanaeff, M.
Majboub, B. Labiad and D. Villemin, Can. J. Chem., 1993, 71, 90–
95.
7 G. Giuglio-Tonolo, T. Terme and P. Vanelle, Synlett, 2005, 251–
254.
8 R. N. Salvatore, A. S. Nagle and K. W. Jung, J. Org. Chem., 2002,
67, 674–683.
9 (a) R. N. Salvatore, S. E. Schmidt, S. I. Shin, A. S. Nagle, J. H.
Worrell and K. W. Jung, Tetrahedron Lett., 2000, 41, 9705–9708;
(b) C. Koradin, A. Rodriguez and P. Knochel, Synlett, 2000, 1452–
1454; (c) D. Tzalis and P. Knochel, Angew. Chem., Int. Ed., 1999, 38,
1463–1465; (d) D. Tzalis, C. Koradin and P. Knochel, Tetrahedron
Lett., 1999, 40, 6193–6195; (e) E. J. Corey, M. C. Noe and F. Xu,
Tetrahedron Lett., 1998, 39, 5347–5350; (f) E. J. Corey, Y. Bo and J.
Busch-Petersen, J. Am. Chem. Soc., 1998, 120, 13000–13001; (g) E. J.
Corey, F. Xu and M. C. Noe, J. Am. Chem. Soc., 1997, 119, 12414–
12415.
dichlorophenyl)piperazin-1-yl]butan-1-ol
3a
NMR
1H
(200 MHz, CDCl3) 7.26 (d, J = 9.0 Hz, 1H), 6.95 (d,
J = 2.9 Hz, 1H), 6.69–6.75 (dd, J = 9.0 and 2.8 Hz, 1H),
3.64–3.56 (m, 2H), 3.47–3.41 (m, 1H), 3.27–3.22 (m, 4H),
2.74–2.69 (m, 4H), 2.50–2.55 (m, 2H), 1.72–1.63 (m, 4H);
NMR 13C (50 MHz, CDCl3) 150.7, 132.7, 130.4, 122.0, 117.1,
115.2, 70.6, 58.3, 52.8, 48.6, 27.7, 23.6; HRMS (EI): calc. for
C14H20N2OCl2 (M+) 303.1025, found 303.1023.
Acknowledgements
This work has been supported by the Centre National de la
Recherche Scientifique and the Universite´ de la Me´diterrane´e.
The authors thank V. Remusat for 1H and 13C spectra recording
and A. Chobert for technical support.
10 R. N. Salvatore, A. S. Nagle, S. E. Schmidt and K. W. Jung, Org.
Lett., 1999, 1, 1893–1896.
11 (a) The 1H NMR, 13C NMR, and MS were identical to those of the
known compounds. For 3b see: J. Ishida, K. Hattori, Y. Kido, and
H. Yamamoto, WO Pat., 2003063874, 2003. For 5a see: R. F. Parcell,
US Pat., 2922788, 1960. For 5b see: C.-G. Wermuth, A. Mann, F.
Garrido, J.-M. Lecomte, J.-C. Schwartz, and P. Sokoloff, EP Pat.,
779284, 1997. For 7c see: L. E. J. Kennis, J. C. Mertens, and S. M. A.
Pieters, WO Pat., 9743271, 1997. For 9c, 9d, 11c and 11d see: Y.-H.
Wu, K. R. Smith, J. W. Rayburn and J. W. Kissel, J. Med. Chem., 1969,
12, 876–881; (b) R. S. Upadhayaya, N. Sinha, S. Jain, N. Kishore, R.
Chandra and S. K. Arora, Bioorg. Med. Chem., 2004, 12, 2225–2238;
(c) E. Schwenner, G. Ladouceur, and T. M. Aune, WO Pat., 9515947,
1995; (d) M. Kurokawa, F. Sato, N. Hatano, Y. Honda and H. Uno,
J. Med. Chem., 1991, 34, 593–599; (e) M. Wierzbicki, P. Hugon, and
J. C. Poignant, EP Pat., 199641, 1986.
Notes and references
1 (a) Y. Oshiro, Y. Sakurai, S. Sato, N. Kurahashi, T. Tanaka, T.
Kikuchi, K. Tottori, Y. Uwahodo, T. Miwa and T. Nishi, J. Med.
Chem., 2000, 43, 177–189; (b) Y. Oshiro, S. Sato, N. Kurahashi, T.
Tanaka, T. Kikuchi, K. Tottori, Y. Uwahodo and T. Nishi, J. Med.
Chem., 1998, 41, 658–667; (c) J. De Antoni and R. Eche, FR Pat.,
1537901, 1968; (d) S. Naruto, T. Tonohiro, M. Sugimoto and N.
Iwata, WO Pat., 9903833, 1999; (e) 4. S. Bengtsson, L. Florvall, G.
Hallnemo, D. Jackson, S. Ross, B. R. Tolf, B. Ulff, L. Zhang, and C.
Aakesson, WO Pat., 9321179, 1993.
2 (a) A. Baeza, C. Najera and J. M. Sansano, Synthesis, 2007, 1230–
1234; (b) S. Bhagat and A. K. Chakraborti, J. Org. Chem., 2007,
162 | Green Chem., 2009, 11, 160–162
This journal is
The Royal Society of Chemistry 2009
©